
























The p53 tumor suppressor gene is activated by 
numerous cellular stressors, including hypoxia and 
DNA damage and may induce cell cycle arrest or 
apoptosis depending on the extent of the damage [1].  
This capacity has earned p53 the title of ‘guardian of the 
genome’ [2] and in 1993, p53 was voted ‘Molecule of 
the Year’ by Science magazine [3].  Since then, the 
extensive study of p53 at both structural and functional 
levels has provided greater insight into its role in cancer 
biology [4].  The fact that p53 functions to suppress 
cancer means that it is essential.  However, recent 
studies in a broad spectrum of model organisms, 
including mice, have shown that not all functions of p53 




One of the first indications that p53 may have a ‘dark 
side’ was the observation that even a slight constitutive 
hyper-activation of p53 results in premature aging 
phenotypes in rodents [6,7].  While adult mice that 
express a hypermorphic truncated p53 allele show a 
dramatic reduction in incidence of cancer, they 
nevertheless have significantly shortened life spans and 
show many hallmarks of early aging, including loss of 
body mass and reduced stress resistance [7].  A severe 
reduction in p53 activity, on the other hand, causes 



























example of antagonistic pleiotropy, where expression in 
early life is beneficial in preventing cancers, but higher 
levels of expression can result in, among other effects, 
detrimental reductions in stem cell pools that maintain 
organ homeostasis [8]. 
 
Recently, studies in Drosophila melanogaster, have 
greatly improved our understanding of the role of p53 in 
modulating the aging process.   Using tissue-specific 
drivers and dominant-negative {DN) p53 alleles, a 
reduction in p53 function in adult neurons was shown to 
have a beneficial effect on longevity [9].  Interestingly, 
life spans of flies that have reduced p53 function in 
adult neuronal cells cannot be further extended by 
dietary restriction (DR) [9], indicating that a decrease in 
p53 activity may be a part of the DR lifespan-extending 
pathway in flies.  Moreover, dSir2, a gene previously 
implicated in mediating response to dietary restriction 
[10], interacts directly with and deacetylates p53, 
inhibiting its function as a transcriptional activator [11].  
One consequence of the lowered p53 activity in adult 
neuronal cells is a reduction in the secretion of 
Drosophila insulin-like peptide 2 (dILP2) without a 
similar reduction in the secretion of other dILPs [12].  
Thus, in addition to its vital role in safeguarding the 
genome, p53 may also tie together the responses 
generated by DR and the insulin/IGF-1 signaling 
pathway. 
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New insights into the roles that p53 plays in animal 
aging are provided by Waskar et al. in this issue of 
Aging.  Following up on previous studies that have 
focused on drawing conclusions about general functions 
of p53 in aging and senescence, Waskar et al. present an 
examination of the specific roles p53 plays in different 
sexes and at different developmental stages.  Provoca-
tively, their results suggest that in addition to the 
developmental antagonistic pleiotropy characteristic of 
the role of p53 as a pro-apoptotic gene [summarized in 
14 and 15], p53 may also function in a sexually 
antagonistic manner, limiting the life span of adult 
female flies while promoting the longevity of adult 
males. 
 
Evidence from rodent studies suggests that increasing 
p53 function using a hypermorphic p53 allele speeds up 
aging in mature animals by depleting the pool of stem 
cells that are necessary to maintain essential functions 
[6].  Furthermore, manipulations of p53 in Drosophila 
life span studies have primarily been concerned with the 
effects of reducing p53 function using DN p53 alleles 
[9, 11, 12].  Reports of wild type p53 over-expression 
have been limited to adults and only in neuronal tissue, 
where it was shown to have little effect on longevity 
[9].  What effect a tissue-general over-expression of 
wild type p53 might have in a largely post-mitotic 
organism has remained an open question.  
 
Weskar et al. make a significant contribution by taking 
advantage of the Drosophila Gene-Switch system that 
puts transcriptional control of a transgene under temporal 
control [16, 17].  By inducing the Dmp53 transgene in a 
tissue general manner in adults, the authors show that in 
female flies, high levels of p53 function results in a 
reduction of life span.  Accordingly, the expression of a 
DN p53 in adult females extends life span, and 
hypomorphic and amorphic mutations of the endogenous 
p53 result in life span extension and moderate stress 
resistance.  Surprisingly, in some cases, the authors find 
the opposite to be true in males, with increased p53 levels 
in adults resulting in longer life spans.  
 
These new findings from Weskar et al. are fascinating, 
providing ‘food for thought’ at several levels. For one 
thing, their findings hint that male and female longevity 
may be limited by different physiological processes. 
The elucidation of the mechanisms that underlie the 
sexual antagonistic pleiotropy demonstrated in this 
study will be of great interest both to studies of life span 
determination and evolution of antagonistic functions 




Moderation has been a hallmark of the longevity field, 
from hormetic effects of toxins [reviewed in 19], to 
dietary restriction [reviewed in 20], to mitochondrial 
gene manipulations [18, 21].  Weskar et al. show that 
the positive effects of p53 on life span are no different.  
In addition to temporal control, the Gene-Switch system 
allows for control of the magnitude of transgene 
expression.  Previous reports of life extension using p53 
manipulations in flies have focused on adults where the 
pro-apoptotic effects of p53 over-expression do not 
interfere with normal development [9].  In the current 
study, the authors find that even during development, 
moderate over-expression of p53 can extend life span.  
Moreover, unlike adults that show sexual antagonistic 
pleiotropy, interventions that extend life span in 
juveniles appear to be beneficial for both sexes.  
 
The slight elevation in p53 may help maintain genomic 
fidelity during early life, resulting in healthier, longer-
lived adults, at the cost of developmental speed and 
elevated energy requirements.  In addition, increased 
p53 activity during development may have resulted in a 
decrease in body mass/size of the animals.   Although 
the relationship between body size and longevity is 
complicated [22], this may be worthy of follow-up 
studies. In addition, an important question that has 
emerged from this study is whether the beneficial 
effects of moderate p53 over-expression during 
developmental stages is the result of a mechanism that 
is distinct from the genome protective effects of higher 
p53 levels.   
 
It has also not escaped our attention that p53 regulates 
mitochondrial electron transport chain (ETC) activity 
[23].  Our own interest in the relationship between ETC 
activity and longevity leads us to speculate that 
alterations in energy metabolism may be important in 
p53-mediated longevity.  Interestingly, we have 
observed stronger effects on female life span in our 
ETC studies [21], though, it is not clear how (or if) this 
relates to the sexual antagonistic pleiotropy seen by 
Waskar et al. with p53. 
 
A final thought worthy of consideration is that it is at 
least possible that the effects observed with neuronal 
expression of DN p53 transgenes could be due to the 
transgenic p53 having effects distinct from inhibition of 
endogenous p53.  The DN p53 has either a mutation in 
the DNA binding domain, or it is a truncated version of 
the protein, but these can presumably still carry out 
some of the functions of p53, such as localization to the 
mitochondria, or direct regulation of autophagy.  In addi- 
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mitotic’ system, there are dividing stem cells and 
progeny cells in the gonad, gut, and malphigian tubule 
[24-28].  Changes in p53 activity could affect the 
maintenance of these cells and consequently, the life 
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